Implementation PRINT PAGE
Technology Description


The IV™flow was designed for use with any gravitational device currently available on the market, as well as a host of additional products.

It is compatible with:

  • Rigid, semi-rigid and collapsible containers (bags and bottles)
  • Oncology sets and oncotherapy
  • Blood and total parenteral nutrition (TPN) transfusion sets and products*
  • Volumetric infusion pumps*

This major breakthrough is due to the fact that it is a value-adding device with no comparable product on the market. Advantages of the IV™flow outstrip ordinary gravity sets.

Due to its technical features and cost-efficiency, the IV™flow is a giant leap forward and an upgrade of existing gravitational infusion technology.

The IV™flow can also be used in conjunction with electronic infusion pumps, which are also sensitive to the hydrostatic pressure in the feedline and vulnerable to infusion containers running empty. The IV™flow will remain in place once a patient is moved from a high care ward where electronic infusion pumps have been used, to wards where these pumps are not available. This will enable other wards to benefit.

Dr. Jaco Makkink, medical doctor and consultant at MX Health, says that “studying the newly developed IV™flow, any critical clinician with experience in the usage of infusion sets immediately becomes aware of the numerous advantages or benefits of the new system’s technology over the currently used infusion set technology.

“As a clinician, one always has the patient’s best interests at heart, especially when administering medicines of any sort or when using infusion methods and technology. The infusion sets for administering fluid into the human body have been around for a very long time (old technology) and the accuracy and effectiveness of the art is to a very large extent taken for granted”. In this regard, the quote from Professor Eliyahu Goldratt’s book The theory of Constraints is relevant to the medical world:

“As long as you think you know all, you stop re-thinking the situation”.

"The entire medical industry needs to seriously take note of the improvement in and upgrade of this newly developed infusion set. These improvements concern both the consistency and accuracy of the clinical infusion process itself (the most important aspect), but also the management and control of the infusion process which is far less dependent on the clinical staff in attendance. It appears that medications which is only administered via digitally controlled drop counters, e.g. Theophylline which is given to a patient with acute asthma, may very well be effectively infused by incorporating this inexpensive but very accurate IV™flow infusion device.

There must be a large number of medical institutions and wards lacking such electronic infusion pumps since they are used in intensive care units. This means that the IV™flow will be perfectly suited to the markets where high quality health care is needed, but at a reduced cost”.

"The care-effectiveness of the IV™flow was proven to be statistically significant and financially relevant.The inclusion of the IV™flow with standard gravitational IV-sets would enhance the quality of patient care and should reduce wastage associated with AE occurrences."
(Ref. SATRGAIT Trial, (Data on file Varori))
“The constant infusion rate, as a direct result of the
IV™flow , saves time since the nurse or clinician has to spend less time counting the droplets to check the correct infusion rate as currently experienced. The nurse can thus spend less time checking the infusion device and more time on the observation of the patient.
(Quote from Mrs. Engela du Plessis – Lecturer at the Nursing School at Potchefstroom University for Christian Higher Education)

The IV™flow prevents the over-hydration or dehydration of the patient, especially where the correct therapeutic concentration is essential such as in the case of kidney or heart conditions.
The maintained infusion rate is of immeasurable value especially in the case where intravenous medication needs to be administered and the precise therapeutic concentration must be maintained.
Incorporation of the
IV™flow also eliminates the need of electronic infusion pumps since it has the same advantages, but with the cost-saving advantage”.

“The results showed a statistically meaningful difference in the accuracy of the flow rate when the IV™flow system was used, compared to standard gravitational dispensing systems. This implies that the add-on of the IV™flow to standard gravitational sets is beneficial with possible ethical implications.”
(Quote from Dr. Ilse Ker – (Department of Physiology University of Pretoria)

* Tests are currently being conducted for the IV™flow’s compatibility with blood products / TPN as well as with volumetric infusion pumps. The results are expected and will be made available in October 2004.